Cargando…
Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma
Edward Libby, MD, and Josh Epworth, ARNP, interpreted data on current and novel treatments, discussed how to select initial therapy based on patient risk and in alignment with guidelines and best practices, and evaluated the use of minimal residual disease testing in patients with multiple myeloma.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Harborside Press LLC
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857329/ https://www.ncbi.nlm.nih.gov/pubmed/33598330 http://dx.doi.org/10.6004/jadpro.2020.11.3.17 |